Literature DB >> 10030522

Decisions loom on selective COX-2 inhibitors.

J L Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030522     DOI: 10.1093/ajhp/56.2.106

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  2 in total

1.  11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis.

Authors:  Shilin Yang; Li Jiang; Ming-Zhi Zhang
Journal:  J Oncobiomarkers       Date:  2013

2.  Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans.

Authors:  Ming-Zhi Zhang; Jie Xu; Bing Yao; Huiyong Yin; Qiuyin Cai; Martha J Shrubsole; Xiwu Chen; Valentina Kon; Wei Zheng; Ambra Pozzi; Raymond C Harris
Journal:  J Clin Invest       Date:  2009-03-23       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.